norverapamil has been researched along with lovastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KS; Choi, DH; Choi, JS; Hong, SP; Koh, YY | 1 |
| Choi, DH; Choi, JS; Chung, JH | 1 |
1 trial(s) available for norverapamil and lovastatin
| Article | Year |
|---|---|
Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.
Topics: Administration, Oral; Adult; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Korea; Lovastatin; Male; Verapamil; Young Adult | 2010 |
1 other study(ies) available for norverapamil and lovastatin
| Article | Year |
|---|---|
Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Topics: Administration, Oral; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Calcium Channel Blockers; Cytochrome P-450 CYP3A; Drug Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Metabolic Detoxication, Phase I; Rats; Rats, Sprague-Dawley; Substrate Specificity; Verapamil | 2009 |